Stan Bukofzer's Net Worth
$330 Thousand
Who is Stan Bukofzer?
Stan Bukofzer does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Assertio Therapeutics, Inc, and Ocera Therapeutics, Inc..
SEC CIK
Stan Bukofzer's CIK is 0001663041
Past Insider Trading and Trends
2019 was Stan Bukofzer's most active year for acquiring shares with 5 total transactions. Stan Bukofzer's most active month to acquire stocks was the month of January. 2020 was Stan Bukofzer's most active year for disposing of shares, totalling 6 transactions. Stan Bukofzer's most active month to dispose stocks was the month of March. 2019 saw Stan Bukofzer paying a total of $26,885.50 for 135,703 shares, this is the most they've acquired in one year. In 2017 Stan Bukofzer cashed out on 710,850 shares for a total of $307,800.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Assertio Therapeutics, Inc No price found
SVP, Chf Scitfc & Tech OfficerStan Bukofzer owns 62,916 units of Common Stock. From 2018 to 2020 Stan Bukofzer acquired a total of 112,698 shares in Assertio Therapeutics, Inc at a cost of $26,885.50, Stan also disposed a total of 31,845 shares of Assertio Therapeutics, Inc equalling to $56,052.11.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +39.88% | 17.94K |
$0.65 | -$4,806.92 | 62.92K |
Apr 2
| |||
Form 4
| +39.88% | 17.94K |
—
|
—
| 62.92K |
Apr 2
| |||
Form 4
| +66.98% | 18.04K |
$1.35 | -$12,885.75 | 44.98K |
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| +17.44% | 4K |
$1.56 | $6,228.00 | 26.94K |
Aug 13
| |||
Form 4
| +358.72% | 17.94K |
$5.16 | -$38,359.44 | 22.94K |
Apr 2
| |||
Form 4
|
∞
| 5K |
$4.13 | $20,657.50 | 5K |
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
| No matching records found | |||||||||
Ocera Therapeutics, Inc. No price found
Chief Medical OfficerStan Bukofzer used to own units in Common Stock but no longer holds any shares there. In the year 2016 Stan Bukofzer acquired a total of 202,500 shares in Ocera Therapeutics, Inc. at a cost of $6,597.50, Stan also disposed a total of 202,500 shares of Ocera Therapeutics, Inc. equalling to $307,800.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -202.50K |
$1.52 | -$307,800.00 |
0
|
Dec 11
| |||
Form 4
| +8,000.00% | 200K |
—
|
—
| 202.5K |
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
∞
| 2.5K |
$2.64 | $6,597.50 | 2.5K |
Oct 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||